LIBZULYN Trademark

Trademark Overview


On Wednesday, November 11, 2020, a trademark application was filed for LIBZULYN with the United States Patent and Trademark Office. The USPTO has given the LIBZULYN trademark a serial number of 79301444. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by NOVARTIS AG. The LIBZULYN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
libzulyn

General Information


Serial Number79301444
Word MarkLIBZULYN
Filing DateWednesday, November 11, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6406000
Registration DateTuesday, July 6, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, November 29, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 8, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 6, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Monday, April 19, 2021NOTIFICATION PROCESSED BY IB
Wednesday, March 31, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 31, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 22, 2021REFUSAL PROCESSED BY IB
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 8, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 1, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 1, 2021REFUSAL PROCESSED BY MPU
Wednesday, February 24, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 23, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 23, 2021ASSIGNED TO EXAMINER
Tuesday, January 19, 2021APPLICATION FILING RECEIPT MAILED
Friday, January 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 14, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 7, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB